“Doing Quality Work, With Vigor”: Designing the Next Generation Pneumococcal Vaccine - Contagionlive.com

Dr. Heather Platt discusses the process of developing V116, a pneumococcal vaccine that targets the serotypes most prevalent in those 65 years and older.

At this weeks International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) in Toronto, Merck presented phase 2 data for its investigational pneumococcal vaccine. The vaccine candidate, V… [+2038 chars]

full article...